AlertWatch

Founded in 2011, AlertWatch emerged as a spin-off from the University of Michigan Health System, born from a direct clinical need identified by Dr. Kevin Tremper, an anesthesiologist with over three decades of experience. Dr. Tremper sought to solve the problem of data overload and alarm fatigue in high-acuity hospital settings, where clinicians are overwhelmed by disparate data from numerous monitors. He envisioned a single, intuitive display that would consolidate real-time and historical patient data to provide clear, actionable insights. The company was co-founded by Dr. Tremper, who serves as President, alongside Justin Adams as CEO and Dr. James Bagian, a former astronaut with a background in patient safety.

AlertWatch develops and markets clinical decision support systems for hospitals, targeting clinicians in operating rooms, intensive care units (ICUs), and labor and delivery units. The company's business model centers on providing this software as a service to healthcare institutions, aiming to improve patient safety and operational efficiency. The firm's revenue is generated by marketing its specialized, FDA-cleared software modules to hospitals. On October 18, 2022, BioIntelliSense, a continuous health monitoring and clinical intelligence company, acquired AlertWatch. This acquisition integrated AlertWatch's platform into BioIntelliSense's portfolio, expanding its distribution reach through a strategic partnership with Medtronic.

The core of AlertWatch's offering is a patient monitoring platform that aggregates, analyzes, and displays patient data from various sources, including electronic medical records (EMRs), physiological monitors, and laboratory systems. This integrated data is presented on a patented, intuitive dashboard that uses color-coded icons (green, yellow, red) to signify a patient's status, allowing for at-a-glance assessment. The platform features specific modules like AlertWatch:OR for the operating room, AlertWatch:OB for maternal safety in labor and delivery, and AlertWatch:AC for other acute care settings. These products have received multiple 510(k) clearances from the U.S. Food and Drug Administration. The system runs over 100 proprietary algorithms and provides automated calculations and alerts for issues such as ventilation management, hemodynamic stability, and antibiotic re-dosing, ultimately helping clinicians to intervene proactively.

Keywords: clinical decision support, patient monitoring, perioperative care, anesthesiology, intensive care unit, labor and delivery, health data aggregation, real-time analytics, EMR integration, clinical intelligence, patient safety, alarm fatigue, medical software, FDA 510(k) clearance, hospital technology, maternal safety, acute care monitoring, vital signs dashboard, surgical outcomes, healthcare analytics